Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria

por Bada, Florence O., Blok, Nick, Okpokoro, Evaezi, Dutt, Saswata, Akolo, Christopher, Dakum, Patrick, Abimiku, Alash’le
Publicado 2020

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria

por Bada, Florence O., Blok, Nick, Okpokoro, Evaezi, Dutt, Saswata, Akolo, Christopher, Dakum, Patrick, Abimiku, Alash’le
Publicado 2021

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria

por Bada, Florence O., Okpokoro, Evaezi, Blok, Nick, Meribole, Emmanuel, Dutt, Saswata, Dakum, Patrick, Abimiku, Alash’le, Zwerling, Alice, Kik, Sandra V.
Publicado 2019

Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study

por Avong, Yohanna Kambai, Jatau, Bolajoko, Gurumnaan, Ritmwa, Danat, Nanfwang, Okuma, James, Usman, Istifanus, Mordi, Dennis, Ukpabi, Blessing, Kayode, Gbenga Ayodele, Dutt, Saswata, El-Tayeb, Osman, Afolabi, Bamgboye, Ambrose, Isah, Agbaji, Oche, Osakwe, Adeline, Ibrahim, Ali, Ogar, Comfort, Nosiri, Helga, Avong, Eunice B., Adekanmbi, Victor, Uthman, Olalekan, Abimiku, Alash’le, Oni, Yetunde O., Mensah, Charles Olalekan, Dakum, Patrick, Mberu, Kamau Edward, Ogundahunsi, Olumide A. T.
Publicado 2018